U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Oxycodone (marketed as OxyContin) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Oxycodone (marketed as OxyContin) Information

 
OxyContin is a prescription narcotic pain reliever. Its active ingredient is oxycodone, a derivative of opium. 

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch program, using the contact information at the bottom of this page.

Related Information

Labeling and Regulatory History from Drugs@FDA

Back to Top